Literature DB >> 18727799

Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya.

J D D Pitout1, G Revathi, B L Chow, B Kabera, S Kariuki, P Nordmann, L Poirel.   

Abstract

This study was designed to characterize the beta-lactamase content of carbapenem-resistant Pseudomonas aeruginosa isolates recovered during 2006 and 2007 in a large tertiary-care centre in Nairobi, Kenya. Molecular characterization was done using PCR and sequencing, and typing was performed using pulsed-field gel electrophoresis (PFGE). In total, 416 P. aeruginosa isolates were obtained during that period, of which 57 (13.7%) were resistant to carbapenems. All carbapenem-resistant isolates tested positive for metallo-beta-lactamase (MBL) production. All MBL isolates produced VIM-2 with two types of integron structures. PFGE identified three clonally related groups of VIM-2-producing P. aeruginosa, including a pan-resistant clone that was responsible for nosocomial outbreaks during 2006 and 2007 in the intensive-care unit. These findings suggest that continuous molecular surveillance needs to be performed to monitor the spread within the hospital of this pan-resistant strain. This study is the first report of VIM-2-producing P. aeruginosa from the African continent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727799     DOI: 10.1111/j.1469-0691.2008.02030.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  27 in total

1.  Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria.

Authors:  Meriem Touati; Seydina M Diene; Mazouz Dekhil; Abdelghani Djahoudi; Abdelkarim Racherache; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

2.  Identification of blaOXA-₅₁-like, blaOXA-₅₈, blaDIM-₁, and blaVIM carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone.

Authors:  Tomasz A Leski; Umaru Bangura; David H Jimmy; Rashid Ansumana; Stephen E Lizewski; Robert W Li; David A Stenger; Chris R Taitt; Gary J Vora
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-β-lactamase production.

Authors:  Divya Bangera; Suchitra M Shenoy; Dominic Rm Saldanha
Journal:  Int Wound J       Date:  2015-10-30       Impact factor: 3.315

Review 4.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

5.  Identification of VIM-2-producing Pseudomonas aeruginosa from Tanzania is associated with sequence types 244 and 640 and the location of blaVIM-2 in a TniC integron.

Authors:  Sabrina Moyo; Bjørg Haldorsen; Said Aboud; Bjørn Blomberg; Samuel Y Maselle; Arnfinn Sundsfjord; Nina Langeland; Ørjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

Review 6.  The accessory genome of Pseudomonas aeruginosa.

Authors:  Vanderlene L Kung; Egon A Ozer; Alan R Hauser
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

7.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.

Authors:  José-Manuel Rodríguez-Martínez; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

8.  VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.

Authors:  Jose-Manuel Rodriguez-Martinez; Patrice Nordmann; Nicolas Fortineau; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

9.  Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African Academic Hospital.

Authors:  Maanda Mudau; Rachael Jacobson; Nadia Minenza; Lazarus Kuonza; Vida Morris; Heather Engelbrecht; Mark P Nicol; Colleen Bamford
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.

Authors:  John Kiiru; Samuel Kariuki; Bruno M Goddeeris; Patrick Butaye
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.